Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer.

Front Oncol · 2023 · PMC10494442 · PMID 37700839

Europe PMC DOI

hedged sentence

0.2007

closest p · 4.0× alpha

0.2007

boldest claim

The sentences

a suggestive trendp= 0.2007not close (p > 0.1)

With regards to EGFR TP53 comutations, there was a suggestive trend towards higher prevalence in women (42/69, 60.87% vs. 15/33, 45.45%, p= 0.2007; q= 0.2007) in HR+ NSCLC.

also in 43 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.